Skip to main content

Table 1 Clinical characteristics and laboratory data of 60 children with transfusion-dependent beta-thalassemia major (TDT)

From: The impact of magnetic resonance imaging in the assessment of iron overload in heart and liver in transfusion-dependent thalassemic children: Minia experience

Characteristics of the studied children Total number = 60
Age (years) 5–15 (13.23 ± 3.01)
Sex
Males/females 38 (63.3%)/22 (36.7%)
Wt. (kg) 18–48 (29.73 ± 4.76)
Height (cm) 110–160 (126.60 ± 12.4)
Duration of the disease (years) 4 -15 (5.88 ± 3.42)
Iron chelating agents
Regular/irregular 32 (53.3%)/28 (46.7%)
Type of chelation therapy
 Deferoxamine monotherapy (SC, IV) 10 (16.6%)
 Deferasirox monotherapy (Oral) 25 (41.7%)
 Deferiprone monotherapy (Oral) 6 (10%)
 Deferoxamine (SC,IV) and deferasirox (Oral) 19 (31.7%)
Splenectomy
Done/not done 34/60 (56.6%)/ 26/60 (43.4%)
Hb level (gm/dl) 7–10.5 (9.01 ± 1.2)
Serum iron (mcg/dl) 650–1200 (803.68 ± 261.36)
Serum ferritin (ng/ ml) 1900–6000 (2639.47 ± 835.06)
  1. SC subcutaneous, IV intravenous
  2. Data presented as a range (mean ± SD)